CRYSTAL DUNN HAD A BABY 156 DAYS AGO. TODAY SHE SCORING 93RD MINUTE WONDER GOALS TO SEND HER TEAM INTO NWSL FINAL. BEYOND INCREDIBLE 🚀🌹🇺🇸

Dare. Dream. Done. ✨ #UCL

Deloitte expands Converge platform to consumer and financial services markets

Great new investment to completely transform a number of industries launched by my colleague @BrettJDavis78 Deloitte by using our Converged software platforms. #ConvergedFS #BaaS #ConvergeHEALTH #ConvergePROSPERITY #DeloitteCloud

Josée’s life was one of many upended by COVID-19. See her story here, and watch the full video to discover how Deloitte helped Quebec build a testing system that brought relief to so many. https://t.co/D8SRL0CqhZ

To all of my friends who are #Athletes - very proud of new research we are doing with @DukeHeartCenter to understand the effects of #COVID19 on the hearts of athletes. Here's how you can be a part of the remote study. https://t.co/nHa7nSdJOm

.@DeloitteUS has been a longstanding and proud advocate for the LGBTQIA+ community—and we will continue to demonstrate our allyship in a visible and impactful way this #PrideMonth, and beyond.

More on less transmission, yet another incentive: "Our results suggest that mRNA-based vaccines do not only prevent #SARSCoV2 infections among vaccinated individuals but lead to a substantial reduction in infections among unvaccinated household members" https://t.co/sIqoOLiH3b

Shaping the Future of Health and our profession – announcing Chris Zant as ConvergeHEALTH’s new General Manager https://t.co/5ZFEFEXwqi via @LinkedIn #futureofhealth #innovation #ConvergeHEALTH

The pandemic has demonstrated that a digital data infrastructure is the foundation for evidence-based decision making & precision public health. The UK govt has leveraged a unique approach with both the private & public sector #Datainhealth #digitalhealth https://t.co/10AXK9JylZ

Excited to launch our new paper with collaborator, the Digital Medicine Society (DiMe), that explores the opportunities, challenges and new operating models required for life sciences companies looking to win with digital medicine… https://t.co/NzXq92alA6

FDA’s Data Modernization Action Plan leverages the foundations laid by our Technology Modernization Action Plan: a modern, cloud-forward technical infrastructure; a product-oriented approach and enhanced collaboration. #FDAVoices

If anyone had a right to question whether our democracy was worth redeeming, it was Dr. Martin Luther King, Jr. Because in the face of billy clubs and lynchings, poll taxes and literacy tests, he never gave in to violence, never waved a traitorous flag or gave up on our country.

30 Years Since the Human Genome Project Began, What’s Next? | #WIRED #personalizedmedicine #digitalhealth #futureofhealth

The UK becomes first country in the world to approve Pfizer's coronavirus vaccine; they plan to begin distributing it next week. This milestone is a culmination of the dedication of the patient volunteers, scientists, regulators, many others. (Disclosure: I serve on Pfizer BoD)

An important development for the progress of advanced diagnostics that can help us detect cancer much earlier, to enable more patients to seek effective therapy when cancers can be successfully addressed; from the team at @GrailBio and @illumina (where I serve on the BoD).

Great day for patients. We may have two highly effective vaccines for Covid if results from the interim Pfizer and Moderna trials are confirmed by the full data sets. The acute phase of the U.S. pandemic will end in 2021. We must work together to get through the next 3 months

Good policy work here, will provide flexibility for the delivery of the Covid antibodies in alternate sites of care; including potentially for home infusion. This can expand access — especially to underserved communities. @LillyPad @Regeneron @CMSGov @SeemaCMS

The scope of clinical trials underway for a Covid vaccine is unprecedented. Never before have so many massive trials been undertaken simultaneously in pursuit of a single goal. The oversight of safety boards is evidence of the integrity, rigor, and careful nature of this process.

Albert Bourla, CEO of Pfizer, writing to the company’s colleagues today on “Moving at the Speed of Science” and the critical importance of integrity and public health mindedness in vaccine development. (where I serve on the company’s Board of Directors)